Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Evaluation of truncated NhhA protein as a candidate meningococcal vaccine antigen.

Peak IR, Srikhanta YN, Weynants VE, Feron C, Poolman JT, Jennings MP.

PLoS One. 2013 Sep 6;8(9):e72003. doi: 10.1371/journal.pone.0072003. eCollection 2013.


Meningococcal omp85 in detergent-extracted outer membrane vesicle vaccines induces high levels of non-functional antibodies in mice.

Wedege E, Lie K, Bolstad K, Weynants VE, Halstensen A, Herstad TK, Kreutzberger J, Nome L, Naess LM, Aase A.

Scand J Immunol. 2013 Jun;77(6):452-9. doi: 10.1111/sji.12051.


An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential.

Stork M, Bos MP, Jongerius I, de Kok N, Schilders I, Weynants VE, Poolman JT, Tommassen J.

PLoS Pathog. 2010 Jul 1;6:e1000969. doi: 10.1371/journal.ppat.1000969.


Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.

Weynants VE, Feron CM, Goraj KK, Bos MP, Denoël PA, Verlant VG, Tommassen J, Peak IR, Judd RC, Jennings MP, Poolman JT.

Infect Immun. 2007 Nov;75(11):5434-42. Epub 2007 Jul 30.


Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region.

Kortekaas J, Pettersson A, van der Biezen J, Weynants VE, van der Ley P, Poolman J, Bos MP, Tommassen J.

Vaccine. 2007 Jan 2;25(1):72-84. Epub 2006 Jul 28.


Immunogenicity and structural characterisation of an in vitro folded meningococcal siderophore receptor (FrpB, FetA).

Kortekaas J, Müller SA, Ringler P, Gregorini M, Weynants VE, Rutten L, Bos MP, Tommassen J.

Microbes Infect. 2006 Jul;8(8):2145-53. Epub 2006 May 24.


Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB.

Pettersson A, Kortekaas J, Weynants VE, Voet P, Poolman JT, Bos MP, Tommassen J.

Vaccine. 2006 Apr 24;24(17):3545-57. Epub 2006 Feb 20.


Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.

Liang FT, Aberer E, Cinco M, Gern L, Hu CM, Lobet YN, Ruscio M, Voet PE Jr, Weynants VE, Philipp MT.

J Infect Dis. 2000 Nov;182(5):1455-62. Epub 2000 Oct 9.


Survival of a bacterioferritin deletion mutant of Brucella melitensis 16M in human monocyte-derived macrophages.

Denoel PA, Crawford RM, Zygmunt MS, Tibor A, Weynants VE, Godfroid F, Hoover DL, Letesson JJ.

Infect Immun. 1997 Oct;65(10):4337-40.


Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB.

Denoel PA, Vo TK, Weynants VE, Tibor A, Gilson D, Zygmunt MS, Limet JN, Letesson JJ.

J Med Microbiol. 1997 Sep;46(9):801-6.


Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle.

Denoel PA, Vo TK, Tibor A, Weynants VE, Trunde JM, Dubray G, Limet JN, Letesson JJ.

Infect Immun. 1997 Feb;65(2):495-502.

Supplemental Content

Loading ...
Support Center